Karyopharm Therapeutics KPTI
NASDAQ KPTI
$1.23 +0.02 (+1.56%)
As of: Sep 30, 2026 · 1:09 PM EDT

Karyopharm Therapeutics Inc. (KPTI) Common Equity (2012 - 2026)

Updated

Karyopharm Therapeutics (KPTI) reported Common Equity of -$330.17 million for Q2 2026, compared with -$238.93 million a year earlier.

Analysis

Karyopharm Therapeutics Inc. (KPTI) Common Equity (2012 - 2026) Analysis & Trends

At the end of FY2025, Karyopharm Therapeutics posted Common Equity of -$292.93 million.

  • By year, Common Equity came in at -$186.02 million in FY2024, -$136.21 million in FY2023, -$16.66 million in FY2022 and -$79.67 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Common Equity in data going back to Q4 2012.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -330.17 Mn
Dec 31, 2025 -292.93 Mn
Sep 30, 2025 -269.26 Mn
Jun 30, 2025 -238.93 Mn
Mar 31, 2025 -205.88 Mn
Dec 31, 2024 -186.02 Mn
Sep 30, 2024 -159.65 Mn
Jun 30, 2024 -132.14 Mn
Mar 31, 2024 -168.96 Mn
Dec 31, 2023 -136.21 Mn
Sep 30, 2023 -100.40 Mn
Jun 30, 2023 -71.25 Mn
Mar 31, 2023 -45.17 Mn
Dec 31, 2022 -16.66 Mn
Sep 30, 2022 -140.28 Mn
Jun 30, 2022 -116.34 Mn
Mar 31, 2022 -83.08 Mn
Dec 31, 2021 -79.67 Mn
Sep 30, 2021 -125.98 Mn
Jun 30, 2021 -83.13 Mn
API Access

Karyopharm Therapeutics Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=KPTI&period=max&api_key=YOUR_API_KEY